|
| 37033104 | Histologic reâ¿¿evaluation of a populationâ¿¿based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification. | Oncol Lett | 2023 |
| 35076935 | Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. | Int J Cancer | 2022 |
| 35444164 | Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. | Sci Rep | 2022 |
| 35584320 | Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste? | Clin Transl Gastroenterol | 2022 |
| 35477541 | Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. | Clin Epigenetics | 2022 |
| 35554535 | Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2022 |
| 34912077 | Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study. | Br J Cancer | 2022 |
| 31402218 | Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review. | Eur Urol Oncol | 2021 |
| 33506581 | Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies. | Mol Oncol | 2021 |
| 33858496 | Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. | Clin Epigenetics | 2021 |
| 33947447 | Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers. | Clin Epigenetics | 2021 |
| 31444787 | SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma. | Histopathology | 2020 |
| 31924838 | Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer. | Sci Rep | 2020 |
| 32098999 | Investigation of sirtuin 1 polymorphisms in relation to the risk of colorectal cancer by molecular subtype. | Sci Rep | 2020 |
| 32005275 | Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review. | Breast Cancer Res | 2020 |
| 32644288 | Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. | Cancer Med | 2020 |
| 32414074 | Past, Present and Future of Epigenetics in Adrenocortical Carcinoma. | Cancers (Basel) | 2020 |
| 32462913 | Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening? | J Comp Eff Res | 2020 |
| 30430425 | Gene Promoter Methylation in Endometrial Carcinogenesis. | Pathol Oncol Res | 2019 |
| 31641693 | The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study. | Diagn Progn Res | 2019 |
| 31764091 | Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. | Am J Gastroenterol | 2019 |
| 31114869 | MEXPRESS update 2019. | Nucleic Acids Res | 2019 |
| 30555044 | Molecular profiling of longitudinally observed small colorectal polyps: A cohort study. | EBioMedicine | 2019 |
| 28733262 | Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening. | Clin Gastroenterol Hepatol | 2018 |
| 29867106 | Epigenetics in renal cell cancer: mechanisms and clinical applications. | Nat Rev Urol | 2018 |
| 30033230 | A combined literature and in silico analysis enlightens the role of the NDRG family in the gut. | Biochim Biophys Acta Gen Subj | 2018 |
| 29666440 | Analysis of DNA methylation in cancer: location revisited. | Nat Rev Clin Oncol | 2018 |
| 29713045 | Author Correction: Analysis of DNA methylation in cancer: location revisited. | Nat Rev Clin Oncol | 2018 |
| 29564023 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. | Clin Epigenetics | 2018 |
| 27649841 | Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study. | Int J Cancer | 2017 |
| 28173852 | Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study. | BMC Cancer | 2017 |
| 28968978 | <i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancer. | Oncotarget | 2017 |
| 29249914 | Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology. | Curr Colorectal Cancer Rep | 2017 |
| 28803494 | Prognostic DNA methylation markers for renal cell carcinoma: a systematic review. | Epigenomics | 2017 |
| 28617096 | Details matter: the role of genomic location and assay standardization in DNA methylation analyses. | Epigenomics | 2017 |
| 28524415 | NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons. | Neurogastroenterol Motil | 2017 |
| 27789672 | Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer. | Int J Epidemiol | 2017 |
| 27756787 | A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients. | Clin Cancer Res | 2017 |
| 27943265 | Assessing opportunities for coordinated R&D in early cancer detection and management in Europe. | Int J Cancer | 2017 |
| 26953528 | The emerging role of GATA transcription factors in development and disease. | Expert Rev Mol Med | 2016 |
| 27686058 | Potential role of gene-environment interactions in ion transport mechanisms in the etiology of renal cell cancer. | Sci Rep | 2016 |
| 27118999 | Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome. | Clin Epigenetics | 2016 |
| 27340879 | Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer. | Nutr Cancer | 2016 |
| 24978482 | Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid. | Int J Cancer | 2015 |
| 26381944 | Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study. | Sci Rep | 2015 |
| 26645898 | Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer. | Discov Med | 2015 |
| 26476438 | Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival. | Carcinogenesis | 2015 |
| 25918983 | Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma. | J Invest Dermatol | 2015 |
| 25867767 | Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays. | Lab Invest | 2015 |
| 25904753 | Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome. | Clin Cancer Res | 2015 |